Work

Phase II trial of pembrolizumab in combination with nab-paclitaxel in patients with metastatic HER2-negative breast cancer.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.tps1124

Authors: Maryann J. Kwa, Alyssa Iwano, Francisco J. Esteva, Yelena Novik, James L. Speyer, Ruth Oratz, Marleen Iva Meyers, Deborah M. Axelrod, Rebecca Hogan, Sandra Mendoza, Judith D. Goldberg, Franco Muggia, Sylvia Adams

Institutions: New York University, NYU Langone’s Laura and Isaac Perlmutter Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2621592748

Cites:

Cited by: 6

Related to: 10